Frontlight ResearchEarly access
Active, not recruitingNo phase
SCOPE-CLI: Shifting Care and Outcomes for Patients With Endangered Limbs
Key facts
- Who runs it
- Yale University
- Where
- New Haven, United StatesSee the site
- Trial code
- Status
- Active, not recruiting
- People taking part
- 458 people enrolled
- Started
- 11 Aug 2021
- Expected to end
- Sept 2028
- Type of study
- Observational
- Record updated
- 20 October 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- All race/ethnicity categories, English speaking, men and women
- Patient presents with current (within 30 days) Rutherford Class 4, 5, or 6
- Age ≥18 years
- Supported by any of the following diagnostic evidence:; Rutherford Classification 4 or ischemic rest pain and/or resting ankle pressure <50mmHg, flat or barely pulsatile ankle or metatarsal PVR or toe pressure <40mmHg; Rutherford Classification 5 or minor tissue loss; non-healing ulcer, focal gangrene with diffuse pedal ischemia resting ankle pressure <50mmHg ankle or metatarsal PVR flat or barely pulsatile or toe pressure <40mmHg; Rutherford Classification 6 or major tissue loss: extending above transmetatarsal level, functional foot no longer salvageable, resting ankle pressure <50mmHg ankle or metatarsal PVR flat or barely pulsatile or toe pressure <40mmHg; CLI related ICD 10 code (reason for admission or indication for procedure); SPP < 50 mmHg; TCPO2 < 50 mmHg; Angiographic evidence no straight line to foot or greater than 70% stenosis in all 3 lower extremity arteries (AT, PT, peroneal); ABI* ≤ 0.90; non-compressible ABI ≥ 1.40 AND TBI ≤ 0.70; TBI* ≤ 0.70
Who cannot take part
- Acute limb ischemia
- Unable to provide written informed consent
- Currently a prisoner (identified at time of enrollment)
Where in United States
- Yale New Haven HealthNew Haven, United States
About the trial
What the trial wants to find out
A research project capturing experiences of patients with critical limb threatening ischemia, with the ultimate goal of setting new standards for diagnosing, describing detailed patient-centered outcomes, and evaluating the variability in therapeutic approaches and their association with outcomes.
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- SCOPE-CLI: Shifting Care and Outcomes for Patients With Endangered Limbs - Critical Limb Ischemia
- Publications
- The shifting care and outcomes for patients with endangered limbs - Critical limb ischemia (SCOPE-CLI) registry overview of study design and rationale.International journal of cardiology. Heart & vasculature, 2022
- Record updated
- 20 October 2025